DENVER, Oct. 22, 2020 /PRNewswire/ -- DaVita
Clinical Research (DCR) will present 14 research abstracts from
company representatives and medical professionals at the American
Society of Nephrology (ASN) annual Kidney Week occurring Oct.
22–25, 2020.
Amid the COVID-19 pandemic, ASN Kidney Week 2020 will
convene more than 13,000 kidney care professionals from around the
world in a virtual format to discuss advancements in the field of
nephrology.
"We believe our commitment to pursuing life-enhancing research
discoveries is helping accelerate transformation in kidney care,"
said Dr. Steven Brunelli, vice
president and medical director of health economics and outcomes
research for DCR. "During these unprecedented times, Kidney Week
continues to be a vital convening platform for clinical experts to
share meaningful insights and potential real-world solutions that
could improve the well-being of medically complex kidney disease
patients."
DaVita researchers will report on findings from multiple
retrospective studies, with a particular focus on how COVID-19
affects dialysis patients, home dialysis treatments and chronic
kidney disease progression.
This year's poster and presentation titles include:
DaVita Clinical Research
- Assessment of a Laboratory-Based SARS-CoV-2 Antibody Test Among
Hemodialysis Patients: A Quality Improvement Initiative
- Management of Secondary Hyperparathyroidism Among Patients Who
Transition from Daily At-Home to 3X Weekly Oral Cinaclect Given
In-Center
- Associations Between Antimicrobial Barrier Cap Use and Outcomes
Among Hemodialysis Patients Using a Central Venous Catheter
- Urgent Start Peritoneal Dialysis and Outcomes
- Longitudinal Assessment of Random Variability in ICH-CAHPS
Scores
- Use of Predictive Analytics to Inform Integrated Care Programs
to Reduce Hospitalizations Among Hemodialysis Patients
- Exploration of Racial Disparities in the Kidney Transplant
Process Among Dialysis Patients
- Use of Incremental Peritoneal Dialysis: Impact on Clinical
Outcomes and Quality-of-Life Measures
- Patterns of Hospital Admissions Among Patients with Chronic
Kidney Disease
- Development and Validation of a Predictive Model to Identify
Patients with Undiagnosed Chronic Kidney Disease
- Inpatient Dialysis Provider Type and Duration of Hospital
Admissions of Dialysis Patients
- Strategies to Prevent Infection-Related Losses in U.S.
Peritoneal Dialysis Programs by More Actionable Predictive Data
Reporting
- Blood Pressure Telemonitoring in Large U.S. Peritoneal Dialysis
Population
- Impact of the COVID-19 Pandemic on Virtual Care in Home
Dialysis
ASN Kidney Week attendees can view ePosters and pre-recorded
presentations from DCR and DaVita Kidney
Care clinical leaders at
https://www.asn-online.org/kidneyweek/ beginning Oct. 22. DaVita representatives will be available
to discuss appropriate opportunities in the Kidney Week digital
exhibit hall. Live updates will be shared throughout the meeting on
Twitter at @DaVitaDoc and @DaVitaResearch. Attendees, as well as
those who cannot participate in the virtual sessions, are
encouraged to join or view the conversation by using #KidneyWk.
To learn more about DCR,
visit davitaclinicalresearch.com.
About DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita
Inc., is the research arm of DaVita. DCR innovates through
retrospective research aimed at improving clinical outcomes. DCR
assists pharmaceutical and medical device companies in the design,
recruitment and completion of clinical trials using its renal
research site network. To learn more about DCR,
visit DaVitaClinicalResearch.com.
About DaVita Inc.
DaVita Inc. (NYSE: DVA) is a health care provider focused on
transforming care delivery to improve quality of life for patients
globally. The company is one of the largest providers of kidney
care services in the U.S. and has been a leader in clinical quality
and innovation for more than 20 years. Through DaVita Kidney
Care, the company treats patients with chronic kidney failure and
end stage kidney disease. DaVita is committed to bold,
patient-centric care models, implementing the latest technologies
and moving toward integrated care offerings for all. Through these
efforts, DaVita has also become the largest provider of home
dialysis in the country. As of June 30, 2020, DaVita served
205,300 patients at 2,795 outpatient dialysis centers
in the United States and operated 287 outpatient dialysis
centers in ten countries worldwide. DaVita has reduced
hospitalizations, improved mortality, and worked collaboratively to
propel the kidney care industry to adopt an equitable and
high-quality standard of care for all patients, everywhere. To
learn more, visit DaVita.com/About.
Contact Information
Media:
Halie Peddle
(303) 550-6349
halie.peddle@davita.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/davita-clinical-research-to-present-new-findings-at-american-society-of-nephrology-kidney-week-2020-301157990.html
SOURCE DaVita Clinical Research